Printer Friendly

IMMUNO RESPONSE TECHNOLOGY SIGNS LETTER OF INTENT

 IMMUNO RESPONSE TECHNOLOGY SIGNS LETTER OF INTENT
 BERLIN, N.J., Feb. 14 /PRNewswire/ -- Immuno Response Technology,


Inc. ("IRT") a privately-held corporation, announced that it has signed a letter of intent to be acquired by L'Autrec, Inc., (NASDAQ: LTRC) a publicly-held business development corporation located in Salt Lake City, Utah.
 IRT markets an allergy/immunology management program for primary care physicians that includes a clinical diagnostic confirmation provided through a network of clinical allergists and immunologists.
 The letter of intent provides that L'Autrec will acquire IRT by forming a new subsidiary which will be merged into IRT with IRT becoming a wholly-owned subsidiary of L'Autrec. L'Autrec will effect a 1-for-4 reverse split in its outstanding shares and the outstanding shares of IRT will be converted into a total of 4,583,333 shares of post-split L'Autrec common stock. Following the transaction L'Autrec will have a total of approximately 5,437,500 shares issued and outstanding, of which 625,000 or 11.5 percent will be held by the L'Autrec shareholders and 4,583,333 or 83 percent will be held by the IRT shareholders.
 As soon as practicable following the execution of a definitive Reorganization Agreement, both IRT and L'Autrec plan to submit proposals to their shareholders to approve the reorganization and the reverse split, change the name of L'Autrec to a name selected by IRT, and elect the designees of IRT as the directors of L'Autrec.
 -0- 2/14/92
 /CONTACT: George Young, president of Immuno Response Technology, Inc., 800-448-8199, or Kenneth L. Latham, 212-642-5896, for Immuno Response Technology/
 (LTRC) CO: Immuno Response Technology Inc.; L'Autrec Inc. ST: New Jersey, Utah IN: MTC SU: TNM


SH-KW -- NY054 -- 0270 02/14/92 14:35 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 14, 1992
Words:284
Previous Article:DEFENSE SECRETARY DICK CHENEY TO ADDRESS IIAA'S ANNUAL NATIONAL LEGISLATIVE CONFERENCE
Next Article:ABBOTT LABORATORIES TO SPLIT STOCK 2-FOR-1; TO INCREASE DIVIDEND 20 PERCENT
Topics:


Related Articles
URETHANE TECHNOLOGIES INC. ANNOUNCES SIGNING OF LETTER OF INTENT
/C O R R E C T I O N -- MEDISYS TECHNOLOGIES, INC./
AMERICAN MEDICAL RESPONSE ANNOUNCES PLANNED ENTRY INTO SOUTHERN CALIFORNIA MARKET
Baxter International Inc. to Defer Tender Offer for Publicly Traded Bearer Shares of Immuno International AG into 1997
Baxter Completes $236 Million Acquisition of Research Medical
Baxter International Closes Third Step In the Acquisition of Immuno International
Bio-Rad and Immucor Announce French Distribution Agreement.
Direct Response Media, Inc. Announces Letter of Intent to Acquire Pangea Pictures Corporation.
JAG Media Holdings, Inc. Announces Update of the Status of its Proposed Acquisition of CardioGenics Inc.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters